Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Pharmacokinetic study and optimal formulation of new anti-Parkinson natural compound schisantherin A
Experimental studies have led to the identification of various cancer cell-intrinsic resistance mechanisms, e.g., activation and/or overexpression of drug transporter proteins (e.g., P-glycoprotein), altered expression of detoxifying enzymes (e.g., glutathione S-transferase) or resistance to apoptosis/senescence pathways [239-242]
June 27, 2026 Iron deficiency anaemia remains the most prevalent
thus, currently available data do not provide sufficient evidence to support the clinical efficacy of aducanumab
US$ 23.82
US$ 21.57
US$ 24.56
US$ 21.80
US$ 26.22
US$ 26.91
US$ 27.99
US$ 20.85
US$ 22.02
US$ 21.92
